Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van den Berg, J. W. K.
Right arrow Articles by Koëter, G. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van den Berg, J. W. K.
Right arrow Articles by Koëter, G. H.
(Chest. 2000;118:1648-1652.)
© 2000 American College of Chest Physicians

Bronchiolitis Obliterans Syndrome and Additional Costs of Lung Transplantation*

Jan W. K. van den Berg, MD, PhD; Petra J. van Enckevort, PhD; Elisabeth M. TenVergert, PhD; Dirkje S. Postma, MD, PhD; Wim van der Bij, MD, PhD and Gerard H. Koëter, MD, PhD

* From the Department of Pulmonology (Drs. van den Berg, Postma, van der Bij, and Koëter) and Office for Medical Technology Assessment (Drs. van Enckevort and TenVergert), University Hospital, Groningen, the Netherlands.

Correspondence to: Jan W. K. van den Berg, MD, PhD, Department of Pulmonology, Isala Clinics, PO Box 10.500, 8000 GM Zwolle, the Netherlands; e-mail: j.w.k.van.den.berg{at}isala.nl

Study objectives: The influence of bronchiolitis obliterans syndrome (BOS) on costs after lung transplantation was investigated by comparing the costs of patients with and without this condition.

Design: Follow-up costs were prospectively investigated in a medical technology assessment of the Dutch Lung Transplant Program, in relation to the development of the BOS. First, average follow-up costs per week per patient were compared between patients who did or did not develop BOS. Second, in the BOS group, these costs were compared before and after the onset of BOS.

Setting: Dutch Lung Transplant Program, University Hospital of Groningen.

Results: Data on 53 patients (37 patients without BOS and 16 with BOS) who underwent transplantation between November 1990 and April 1995 were available. The average follow-up time of these 53 patients was 1.5 years. The follow-up costs amounted to an average (in Dutch guilders [Dfl]) of 1,774/wk for non-BOS patients, compared to 3,072/wk for BOS patients (+ 73%; p = 0.002; one Dfl = 50 cents US currency). This difference in costs was largely accounted for by an increase in used health-care resources, in particular hospitalization and medication. For the BOS patients, the average costs per week before and after the onset of BOS were 1,941 Dfl and 2,422 Dfl, respectively.

Conclusion: BOS is associated with substantial extra costs. These findings reemphasize the need to focus efforts on prevention of BOS to enhance the cost-effectiveness of lung transplantation.

Key Words: bronchiolitis obliterans • cost analysis • lung transplantation




This article has been cited by other articles:


Home page
Eur Respir JHome page
A. Boehler and M. Estenne
Post-transplant bronchiolitis obliterans
Eur. Respir. J., December 1, 2003; 22(6): 1007 - 1018.
[Abstract] [Full Text] [PDF]


Home page
Am J Crit CareHome page
A. DeVito Dabbs, L. A. Hoffman, A. T. Iacono, C. L. Wells, W. Grgurich, T. G. Zullo, K. R. McCurry, and J. H. Dauber
Pattern and Predictors of Early Rejection After Lung Transplantation
Am. J. Crit. Care., November 1, 2003; 12(6): 497 - 507.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American College of Chest Physicians.